GFM
RCKT icon

GF Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History

GF Fund Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.87K Sell
2,300
-114
-5% -$379 ﹤0.01% 550
2026
Q1 		$8.64K Buy
2,414
+289
+14% +$1.15K ﹤0.01% 570
2025
Q4 		$7.46K Sell
2,125
-196
-8% -$671 ﹤0.01% 602
2025
Q3 		$7.57K Sell
2,321
-12
-0.5% -$38 ﹤0.01% 576
2025
Q2 		$5.72K Hold
2,333
– – ﹤0.01% 619
2025
Q1 		$15.6K Buy
2,333
+419
+22% +$4.14K ﹤0.01% 524
2024
Q4 		$24.1K Buy
+1,914
New +$28.8K ﹤0.01% 457

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GF Fund Management's RCKT Position: Q2 2026 in Review

GF Fund Management reduced its Rocket Pharmaceuticals (RCKT) stake by 4.7% in Q2 2026, selling an estimated $379 and leaving 2,300 shares worth $7.87K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

GF Fund Management first reported a position in RCKT in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.1K in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • GF Fund Management held 2,300 shares of Rocket Pharmaceuticals worth $7.87K as of Q2 2026.
  • GF Fund Management sold 114 Rocket Pharmaceuticals shares in Q2 2026, an estimated $379.
  • Rocket Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #550 holding.
  • GF Fund Management first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Rocket Pharmaceuticals position peaked at $24.1K in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.